Trinity Biotech (Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system. Dublin, Ireland-based Trinity’s trial included 30 ...

The MiniMed 780G with the Simplera Sync CGM and accompanying devices. [Image courtesy of Medtronic] The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline ...

Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] Insulet (Nasdaq:PODD) announced today that it launched the Omnipod 5 system in five more European countries. The company now offers the ...

The Stelo glucose monitor for people with diabetes who are not taking insulin. [Image courtesy of Dexcom] After a busy 2024, Dexcom (Nasdaq:DXCM) Chair and CEO Kevin Sayer believes the company is set ...

Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital ...

Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. BTIG’s Marie Thibault, Sam Eiber and ...

The iLet bionic pancreas. [Image courtesy of Beta Bionics] Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public offering (IPO). The ...

Beta Bionics celebrates its formal listing on the Nasdaq market. [Image from the company’s LinkedIn page] Beta Bionics (Nasdaq:BBNX) announced today that it went public after pricing a significantly ...

The FreeStyle Libre 3 reader with the sensor and smartphone. [Image courtesy of Abbott] Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter ...

The iLet bionic pancreas. [Image courtesy of Beta Bionics] Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO). Earlier this month, ...

The CeQur Simplicity wearable insulin delivery device. [Image courtesy of CeQur] CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology ...

A pickleball player wears the Stelo over-the-counter CGM. [Image courtesy of Dexcom] Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic ...